{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:42:51Z","timestamp":1781034171236,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GY1333A"],"award-info":[{"award-number":["01GY1333A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40266-018-0550-6","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T03:11:46Z","timestamp":1525749106000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-3059","authenticated-orcid":false,"given":"Katharina Luise","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weckbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bleckwenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"B\u00f6hme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Carolin","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"issue":"7","key":"550_CR1","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):e102149.","journal-title":"PLoS One"},{"issue":"1","key":"550_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57\u201365.","journal-title":"Expert Opin Drug Saf."},{"issue":"1","key":"550_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/13814780701815116","volume":"14","author":"L Bjerrum","year":"2008","unstructured":"Bjerrum L, Gonzalez Lopez-Valcarcel B, Petersen G. Risk factors for potential drug interactions in general practice. Eur J Gen Pract. 2008;14(1):23\u20139.","journal-title":"Eur J Gen Pract."},{"issue":"1","key":"550_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00002018-200528010-00005","volume":"28","author":"YF Chen","year":"2005","unstructured":"Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous\/contraindicated drug combinations in general practice. Drug Saf. 2005;28(1):67\u201380.","journal-title":"Drug Saf"},{"issue":"4","key":"550_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00002512-200825040-00007","volume":"25","author":"LR Tulner","year":"2008","unstructured":"Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging. 2008;25(4):343\u201355.","journal-title":"Drugs Aging"},{"key":"550_CR6","first-page":"2079","volume":"9","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079\u201386.","journal-title":"Clin Interv Aging"},{"issue":"7","key":"550_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1345\/aph.1L037","volume":"42","author":"C Kongkaew","year":"2008","unstructured":"Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017\u201325.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"550_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/pds.1351","volume":"16","author":"ML Becker","year":"2007","unstructured":"Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641\u201351.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"550_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40264-017-0528-z","volume":"40","author":"N Parameswaran Nair","year":"2017","unstructured":"Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, et al. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf. 2017;40(7):597\u2013606.","journal-title":"Drug Saf"},{"issue":"3","key":"550_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00228-012-1338-y","volume":"69","author":"ML Andersson","year":"2013","unstructured":"Andersson ML, Bottiger Y, Lindh JD, Wettermark B, Eiermann B. Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. Eur J Clin Pharmacol. 2013;69(3):565\u201371.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"550_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1532-5415.2009.02352.x","volume":"57","author":"KM Terrell","year":"2009","unstructured":"Terrell KM, Perkins AJ, Dexter PR, Hui SL, Callahan CM, Miller DK. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: a randomized, controlled trial. J Am Geriatr Soc. 2009;57(8):1388\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"550_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-010-1778-8","volume":"36","author":"T Bertsche","year":"2010","unstructured":"Bertsche T, Pfaff J, Schiller P, Kaltschmidt J, Pruszydlo MG, Stremmel W, et al. Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med. 2010;36(4):665\u201372.","journal-title":"Intensive Care Med"},{"issue":"1","key":"550_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40266-015-0329-y","volume":"33","author":"D O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan D, O\u2019Mahony D, O\u2019Connor MN, Gallagher P, Gallagher J, Cullinan S, et al. Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial. Drugs Aging. 2016;33(1):63\u201373.","journal-title":"Drugs Aging"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12875-016-0447-6","volume":"17","author":"JC Stingl","year":"2016","unstructured":"Stingl JC, Kaumanns KL, Claus K, Lehmann ML, Kastenmuller K, Bleckwenn M, et al. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug)\u2014study protocol for a pragmatic randomized controlled trial. BMC Fam Pract. 2016;17:49.","journal-title":"BMC Fam Pract."},{"issue":"5","key":"550_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/pds.3592","volume":"23","author":"S Dechanont","year":"2014","unstructured":"Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23(5):489\u201397.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"550_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/pds.3915","volume":"25","author":"M Heringa","year":"2016","unstructured":"Heringa M, Floor-Schreudering A, Tromp PC, de Smet PA, Bouvy ML. Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy. Pharmacoepidemiol Drug Saf. 2016;25(1):82\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"550_CR17","first-page":"427","volume":"9","author":"JM Cruciol-Souza","year":"2006","unstructured":"Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9(3):427\u201333.","journal-title":"J Pharm Pharm Sci."},{"issue":"2","key":"550_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2125.2009.03443.x","volume":"68","author":"JE Zwart-van Rijkom","year":"2009","unstructured":"Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC. Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol. 2009;68(2):187\u201393.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"550_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00228-006-0143-x","volume":"62","author":"B Astrand","year":"2006","unstructured":"Astrand B, Astrand E, Antonov K, Petersson G. Detection of potential drug interactions\u2014a model for a national pharmacy register. Eur J Clin Pharmacol. 2006;62(9):749\u201356.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"550_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/bcp.12754","volume":"80","author":"E Raschi","year":"2015","unstructured":"Raschi E, Piccinni C, Signoretta V, Lionello L, Bonezzi S, Delfino M, et al. Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice. Br J Clin Pharmacol. 2015;80(6):1411\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"550_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clpt.2004.02.009","volume":"76","author":"V Bergk","year":"2004","unstructured":"Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther. 2004;76(1):85\u201396.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"550_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00228-002-0557-z","volume":"58","author":"SS Egger","year":"2003","unstructured":"Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58(11):773\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"550_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1177\/0091270010378858","volume":"51","author":"L Reimche","year":"2011","unstructured":"Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011;51(7):1043\u201350.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"550_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2710.2009.01021.x","volume":"34","author":"A Nobili","year":"2009","unstructured":"Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34(4):377\u201386.","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"550_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","volume":"30","author":"K Johnell","year":"2007","unstructured":"Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf. 2007;30(10):911\u20138.","journal-title":"Drug Saf"},{"issue":"9","key":"550_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2165\/11538460-000000000-00000","volume":"27","author":"SR Secoli","year":"2010","unstructured":"Secoli SR, Figueras A, Lebrao ML, de Lima FD, Santos JL. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs Aging. 2010;27(9):759\u201370.","journal-title":"Drugs Aging"},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2147\/TCRM.S109214","volume":"12","author":"E Blozik","year":"2016","unstructured":"Blozik E, Signorell A, Reich O. How does hospitalization affect continuity of drug therapy: an exploratory study. Ther Clin Risk Manag. 2016;12:1277\u201383.","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"550_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2165\/00002512-200825100-00005","volume":"25","author":"N Mansur","year":"2008","unstructured":"Mansur N, Weiss A, Hoffman A, Gruenewald T, Beloosesky Y. Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging. 2008;25(10):861\u201370.","journal-title":"Drugs Aging"},{"key":"550_CR29","doi-asserted-by":"crossref","unstructured":"Martin P, Haefeli WE, Martin-Facklam M. A drug database model as a central element for computer-supported dose adjustment within a CPOE system. J Am Med Inform Assoc. 2004;11(5):427\u201332.","DOI":"10.1197\/jamia.M1296"},{"issue":"8","key":"550_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2165\/00002512-200825080-00005","volume":"25","author":"HM Hosia-Randell","year":"2008","unstructured":"Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25(8):683\u201392.","journal-title":"Drugs Aging"},{"issue":"6","key":"550_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2165\/11589070-000000000-00000","volume":"28","author":"R Ljung","year":"2011","unstructured":"Ljung R, Lu Y, Lagergren J. High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study. Drugs Aging. 2011;28(6):469\u201376.","journal-title":"Drugs Aging"},{"key":"550_CR32","first-page":"33","volume":"2016","author":"M Butkiewicz","year":"2016","unstructured":"Butkiewicz M, Restrepo NA, Haines JL, Crawford DC. Drug-drug interaction profiles of medication regimens extracted from a de-identified electronic medical records system. AMIA Jt Summits Transl Sci Proc. 2016;2016:33\u201340.","journal-title":"AMIA Jt Summits Transl Sci Proc."},{"issue":"2","key":"550_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","volume":"71","author":"T Roblek","year":"2015","unstructured":"Roblek T, Vaupotic T, Mrhar A, Lainscak M. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71(2):131\u201342.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"550_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40264-014-0141-3","volume":"37","author":"S Schmiedl","year":"2014","unstructured":"Schmiedl S, Rottenkolber M, Hasford J, Rottenkolber D, Farker K, Drewelow B, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug Saf. 2014;37(4):225\u201335.","journal-title":"Drug Saf"},{"issue":"4","key":"550_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/pds.3591","volume":"23","author":"EK Ahn","year":"2014","unstructured":"Ahn EK, Kam HJ, Park DK, Jung EY, Lee Y, Park RW. Differences among admitting departments in alerts and alert overrides for drug-drug interaction. Pharmacoepidemiol Drug Saf. 2014;23(4):390\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"550_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4338\/ACI-2013-12-RA-0103","volume":"5","author":"AD Bryant","year":"2014","unstructured":"Bryant AD, Fletcher GS, Payne TH. Drug interaction alert override rates in the meaningful use era: no evidence of progress. Appl Clin Inform. 2014;5(3):802\u201313.","journal-title":"Appl Clin Inform."},{"issue":"12","key":"550_CR37","doi-asserted-by":"publisher","first-page":"e85071","DOI":"10.1371\/journal.pone.0085071","volume":"8","author":"SP Slight","year":"2013","unstructured":"Slight SP, Seger DL, Nanji KC, Cho I, Maniam N, Dykes PC, et al. Are we heeding the warning signs? Examining providers\u2019 overrides of computerized drug-drug interaction alerts in primary care. PLoS One. 2013;8(12):e85071.","journal-title":"PLoS One"},{"issue":"12","key":"550_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10916-016-0628-9","volume":"40","author":"CS Kruse","year":"2016","unstructured":"Kruse CS, Kristof C, Jones B, Mitchell E, Martinez A. Barriers to electronic health record adoption: a systematic literature review. J Med Syst. 2016;40(12):252.","journal-title":"J Med Syst"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0550-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T20:15:20Z","timestamp":1557260120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0550-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0550-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"8 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The IDrug study is financially supported by a research grant from the Federal Ministry of Education and Research (Grant Number 01GY1333A).\u00a0Our application for a Post-Grant-Fund from the Federal Ministry of Education and Research for payment of the open access fee is currently being processed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Katharina Luise Schneider, Kathrin Kastenm\u00fcller, Klaus Weckbecker, Markus Bleckwenn, Miriam B\u00f6hme and Julia Carolin Stingl declare that they have no conflict of interest with the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committees of the University of Bonn, of the Medical Association of North Rhine and of the Medical Association of Rhineland-Palatinate and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the IDrug study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}